ライフサイエンスコーパス: clinicopathologic

1 We performed a clinicopathologic analysis of cases of pregnancy-associa

2 integrate multiple experimental models with clinicopathologic analysis of patient tumors to delineat

3 A) expression of GRPR, SSTR2, and CXCR4 with clinicopathologic and biologic factors, and with prognos

4 ast cancer tissues and correlated with known clinicopathologic and biologic factors, disease-free sur

5 Clinicopathologic and follow-up data on 4661 patients tr

6 Complete clinicopathologic and follow-up data were available for

7 Combining clinicopathologic and genomic variables among tumors ari

8 The diagnosis relies on characteristic clinicopathologic and immunopathologic features.

9 Clinicopathologic and laboratory investigations were per

10 ast cancers (2,608 carcinomas) to assess the clinicopathologic and molecular features and prognostic

11 breast cancer differs on the basis of tumor clinicopathologic and molecular features.

12 Correlated clinicopathologic and molecular genetic studies gave ris

13 Clinicopathologic and outcome data were assessed from re

14 ectively, and correlated those findings with clinicopathologic and outcome features.

15 Clinicopathologic and outcomes data were recorded, and d

16 The objective of this study is to conduct a clinicopathologic and polarized light microscopy (PLM) a

17 We describe the clinicopathologic and prognostic parameters of a series

18 COX-2, and VEGF status were correlated with clinicopathologic and survival data.

19 Univariate analyses of clinicopathologic and treatment factors were performed,

20 Associations of clinicopathologic and treatment factors with tamoxifen u

21 Although demographic, clinicopathologic, and socioeconomic differences may aff

22 Associations between molecular, clinicopathologic, and survival data were analyzed.

23 ary to previous mastocytosis and shares more clinicopathologic aspects with systemic mastocytosis tha

24 However, its clinicopathologic associations have not been the focus o

25 A clinicopathologic case series describing the phenotype o

26 e-transplant patient who developed cutaneous clinicopathologic changes suggestive of CR.

27 Clinicopathologic characteristics and 3-year survival ra

28 A3B expression is associated with aggressive clinicopathologic characteristics and adverse outcomes a

29 ctional parameters and EBV DNA load with the clinicopathologic characteristics and clinical outcomes

30 the expression levels of KISS1 in PCas with clinicopathologic characteristics and to assess the biol

31 high expression of Bmi-1 and the associated clinicopathologic characteristics in esophageal adenocar

32 rmed a case-comparison study to document the clinicopathologic characteristics of LUS tumors and thei

33 The clinicopathologic characteristics of malignant mesotheli

34 were more commonly associated with high-risk clinicopathologic characteristics of PTC than they were

35 independently of Breslow thickness and other clinicopathologic characteristics suggests that amelanot

36 Clinicopathologic characteristics were correlated with S

37 Imaging appearances and clinicopathologic characteristics were correlated with t

38 ER status, progesterone status, clinicopathologic characteristics, and patient age were

39 The association between tumor BF, clinicopathologic characteristics, and patients' overall

40 ata regarding the storage duration of PRBCs, clinicopathologic characteristics, and perioperative out

41 ata regarding the storage duration of PRBCs, clinicopathologic characteristics, and perioperative out

42 After adjustment for patient demographic and clinicopathologic characteristics, increasing age was as

43 Demographic data, clinicopathologic characteristics, interval resection ra

44 ease and high recurrence risk, as defined by clinicopathologic characteristics, may experience improv

45 Clinicopathologic characteristics, operative details, an

46 We collected clinicopathologic characteristics, patients' outcomes, a

47 In a multivariable model including clinicopathologic characteristics, relative to WT melano

48 Clinicopathologic characteristics, treatment regimens, a

49 When adding the immune module to clinicopathologic characteristics, we observed substanti

50 .05 for all), but there was no variation in clinicopathologic characteristics.

51 aled modules with and without adjustment for clinicopathologic characteristics.

52 OH/AI events were correlated with presenting clinicopathologic characteristics.

53 hed with 100 NO-VASC patients having similar clinicopathologic characteristics.

54 to 14.97), which remained significant after clinicopathologic cofactor adjustments.

55 Longitudinal clinicopathologic cohort study with up to 12 years of an

56 and genome-wide association study in a joint clinicopathologic cohort, including 725 deceased subject

57 ssociation studies were evaluated in a joint clinicopathologic cohort.

58 Clinicopathologic comparisons among luminal A and B subt

59 EoE is defined as an immune-mediated clinicopathologic condition characterized by oesophageal

60 s (EoE) is a chronic immune/antigen-mediated clinicopathologic condition that has become an increasin

61 y updated guidelines emphasize that EoE is a clinicopathologic condition.

62 ients with conventional HCC (cHCC) served as clinicopathologic controls.

63 oscopy (EVD) with derm dotting (DD) improves clinicopathologic correlation and the quality of diagnos

64 oscopy (EVD) with derm dotting (DD) improves clinicopathologic correlation and the quality of diagnos

65 Clinicopathologic correlation of consecutive group D eye

66 Clinicopathologic correlation of cutaneous lesions and g

67 This is an important clinicopathologic correlation of NV secondary to AMD in

68 Clinicopathologic correlation of punctate spots was perf

69 A high index of suspicion and careful clinicopathologic correlation on the part of transplant

70 Clinicopathologic correlation revealed increased stainin

71 mination, a notion that can now be tested in clinicopathologic correlation studies.

72 Clinicopathologic correlation was made by determining th

73 Cases with adequate material for clinicopathologic correlation were selected for further

74 Clinicopathologic correlation.

75 This study analyzed the clinicopathologic correlations and prognostic meaning of

76 Clinicopathologic correlations further identified associ

77 iable analysis adjusting for demographic and clinicopathologic covariates, PORT (hazard ratio, 0.80;

78 hat were well-characterized by gold standard clinicopathologic criteria (training set) and an indepen

79 The performance characteristics of clinicopathologic criteria for the identification of bia

80 g adults (AYAs) is not reliably predicted by clinicopathologic criteria.

81 Clinicopathologic data and outcomes for 378 patients tre

82 Clinicopathologic data from a pancreatic cancer database

83 Clinicopathologic data from a population-based endometri

84 Clinicopathologic data from a total of 700 patients was

85 Clinicopathologic data including age, tumor size, histol

86 s, and integrating DNA and RNA analysis with clinicopathologic data may be a crucial step toward pers

87 ormat and analyzed the co-expression and the clinicopathologic data of ERG and IL-6 using immunohisto

88 Tumor samples, blood, and clinicopathologic data were prospectively collected and

89 Clinicopathologic data were retrospectively collected fo

90 py between 1997 and 2005 were identified and clinicopathologic data were used to determine the CPS+EG

91 developed such a tool through integration of clinicopathologic data with image analysis and quantitat

92 Patient demographics and comorbidities, clinicopathologic data, and long-term outcomes among pat

93 Clinicopathologic data, recurrence patterns, and recurre

94 n appropriately integrated with high-quality clinicopathologic data.

95 le staining and correlated the read-out with clinicopathologic data.

96 mous disorder with limited epidemiologic and clinicopathologic data.

97 tprostatectomy, as well as within nearly all clinicopathologic, demographic, and treatment subgroups.

98 Reevaluation of clinicopathologic diagnoses and histopathologic findings

99 and molecular features of 33 patients with a clinicopathologic diagnosis of histiocytoid Sweet syndro

100 With EVD and DD, a specific clinicopathologic diagnosis was made in 27.7% of nevi co

101 sue lacks lymphatic vessels and analyzed the clinicopathologic differences between patients with acut

102 Eosinophilic esophagitis is a clinicopathologic disease of increasing worldwide preval

103 phagitis (EoE) is a chronic antigen-mediated clinicopathologic disease of the esophagus characterized

104 We suggest that this distinctive clinicopathologic entity be called pregnancy-associated

105 AITL is a rare clinicopathologic entity characterized by an aggressive

106 FSGS is a clinicopathologic entity characterized by nephrotic synd

107 ofibrosis with myeloid metaplasia (MMM) is a clinicopathologic entity characterized by stem cell-deri

108 ntified in the 1500s and defined as a unique clinicopathologic entity in 1809.

109 d agglutinin disease (CAD) is a well-defined clinicopathologic entity in which a bone marrow clonal B

110 Eosinophilic esophagitis (EoE) is a clinicopathologic entity of increasing worldwide prevale

111 Hairy cell leukemia (HCL) is a distinct clinicopathologic entity that responds well to purine an

112 cell lymphoma (ALCL) is a recently described clinicopathologic entity that usually presents as an eff

113 Atrial GCM represents a distinct clinicopathologic entity with a more favorable prognosis

114 Human gammadelta T-cell lymphoma is a rare clinicopathologic entity with aggressive course and poor

115 rt the distinction of NMZL as an independent clinicopathologic entity within the current lymphoma cla

116 r, PCNS PTLD appears to represent a distinct clinicopathologic entity within the PTLD spectrum that i

117 60% of ALCL patients established a distinct clinicopathologic entity.

118 ithin hours of administration and suppresses clinicopathologic expression of experimental autoimmune

119 currence beyond that obtained from classical clinicopathologic factors (age, nodal status, tumor size

120 early breast cancer using readily available clinicopathologic factors and can aid individualized cli

121 was used to analyze the association between clinicopathologic factors and overall survival time.

122 determine the association of BRAF V600E with clinicopathologic factors and patient outcome.

123 Clinicopathologic factors and the performance of the Mem

124 s 52 months; P = 0.009) independent of other clinicopathologic factors and type of curative treatment

125 Clinicopathologic factors associated with LN positivity

126 ariable analyses were performed to determine clinicopathologic factors associated with LRR.

127 eated with preoperative CMT; and to identify clinicopathologic factors associated with residual disea

128 Clinicopathologic factors associated with residual disea

129 retrospective study were to characterize the clinicopathologic factors associated with the presentati

130 SLNB use was associated with clinicopathologic factors but also with health system fa

131 Multivariate analysis of clinicopathologic factors for disease-specific survival

132 tudies of mostly larger tumors found that no clinicopathologic factors had significant prognostic val

133 ffect of ALDH1 expression was independent of clinicopathologic factors in the Yale cohort (risk ratio

134 astoma have been associated with a number of clinicopathologic factors including age and neurologic s

135 ngraftment does not appear to correlate with clinicopathologic factors or patient survival.

136 ognostic influence of margin width and other clinicopathologic factors were analyzed.

137 gically confirmed ALN status and other known clinicopathologic factors were examined using ANOVA and

138 be considered for systemic therapy based on clinicopathologic factors with known prognostic signific

139 Unlike conventional clinicopathologic factors, high numbers of FOXP3-positiv

140 Clinicopathologic factors, including extent of microscop

141 Using common clinicopathologic factors, the recurrence nomogram is be

142 lls were not associated with even one single clinicopathologic feature examined.

143 androgen receptor was selected, along with 5 clinicopathologic features (seminal vesicle invasion, bi

144 a chronic mature B-cell neoplasm with unique clinicopathologic features and an initial exquisite sens

145 Conclusion Clinicopathologic features and outcomes of children with

146 This study examines the clinicopathologic features and outcomes of IPNB.

147 ssigned tissue of origin was compatible with clinicopathologic features and response to treatment.

148 The odds of TIL grades associated with clinicopathologic features and survival by TIL grade wer

149 rs was significantly associated with adverse clinicopathologic features and the absence of MSI.

150 Cox proportional hazards models adjusted for clinicopathologic features and time to recurrence (data

151 The results were correlated with the clinicopathologic features and translocation statuses to

152 pendent primary tumors on the basis of their clinicopathologic features are indeed independent occurr

153 exon 19 deletion mutations and show distinct clinicopathologic features associated with a significant

154 Here, we compared endoscopic and clinicopathologic features between early proximal gastri

155 the most informative family member, evolving clinicopathologic features can identify individual patie

156 ed multifocal IPMNs were collected and their clinicopathologic features catalogued.

157 edict relapse more accurately than classical clinicopathologic features have been developed.

158 The clinicopathologic features in our 3 cases best correspon

159 nt recurrence more accurately that classical clinicopathologic features in patients with ER-positive

160 lointerstitial nephritis (IgG4-TIN), but its clinicopathologic features in the kidney are not well de

161 We report the unique clinicopathologic features of a patient with systemic ma

162 MDS/MPNs have clinicopathologic features of both MDS and MPN diseases.

163 Unfamiliarity with the distinctive clinicopathologic features of EB pruriginosa led to an i

164 Here we describe clinicopathologic features of Ebola virus disease in pre

165 Overall, Tg(A116V) mice recapitulate many clinicopathologic features of GSS(A117V) that are distin

166 phenotype, whereas BALB/c mice displayed the clinicopathologic features of HLH, as set forth in the H

167 nsity of monitoring, delays in diagnosis, or clinicopathologic features of late AR.

168 of human breast cancer and retain the major clinicopathologic features of primary tumors.

169 of B7-H3 intensity correlate with worsening clinicopathologic features of prostate cancer.

170 Recent studies have shed light on the clinicopathologic features of the histologic subtypes of

171 an important role of the cell-of-origin for clinicopathologic features of this disease.

172 The characteristic clinicopathologic features of this disorder allow differ

173 on of Jak2V617F, but not Jak2wt, resulted in clinicopathologic features that closely resembled PV in

174 ing therapy empirically based on a patient's clinicopathologic features to using biomarker-driven tre

175 tations was assessed, and relationships with clinicopathologic features were examined.

176 We compared molecular and clinicopathologic features with disease-free survival.

177 he surgical resection specimens and compared clinicopathologic features with overall survival.

178 The association of clinicopathologic features with SLN status, lymph node r

179 d" cohort), and on the basis of (ii) classic clinicopathologic features, (iii) clinical subtypes, (iv

180 On the basis of clinicopathologic features, an exercise-associated reduc

181 recombination-deficient (HRD) status on the clinicopathologic features, chemotherapy response, and s

182 sized prognostic impact and association with clinicopathologic features, including tumor size and inv

183 We compare in detail the clinicopathologic features, nomogram scores, and rates o

184 Clinicopathologic features, patient outcomes, GEP classi

185 cipher score, along with routinely available clinicopathologic features, to identify patients who wou

186 invasive ductal carcinomas (IDC) matched on clinicopathologic features.

187 ole, adding value to estimates with standard clinicopathologic features.

188 n age (mean, 66 v 73 years; P = .6) or other clinicopathologic features.

189 dividuals who benefit from chemotherapy than clinicopathologic features.

190 or survival and higher incidence of negative clinicopathologic features.

191 activity of primary uveal melanoma and other clinicopathologic features.

192 o recurrence, overall survival, and standard clinicopathologic features.

193 ular analyses were compared with genetic and clinicopathologic features.

194 This case series details the clinicopathologic findings of patients with ABBA disease

195 Clinicopathologic findings, pretreatment leukocyte value

196 evels furthered classification and reflected clinicopathologic findings, while sequential tryptase me

197 review focuses on integrating findings from clinicopathologic, genetic, and epigenetic studies, whic

198 athogenic mechanisms underlying the observed clinicopathologic heterogeneity in PD are still not well

199 The clinicopathologic heterogeneity of myelodysplastic syndr

200 Despite their clinicopathologic heterogeneity, malignant germ cell tum

201 is a retrospective case series study of the clinicopathologic, immunohistochemical, and molecular fe

202 Data were collected regarding demographics, clinicopathologic information, tumor and genetic testing

203 lyses, which were corrected for conventional clinicopathologic markers, Mammostrat provided significa

204 was a significant improvement on either the clinicopathologic model or subtype model alone.

205 y predicts risk of RCC death beyond existing clinicopathologic models, particularly in low- and inter

206 Clinicopathologic, morbidity, and survival data were col

207 Clinicopathologic, NCB, and surgical data were collected

208 in terms of the distribution of patients by clinicopathologic or treatment-related (ADT use and leng

209 et of PC biomarkers that predict the risk of clinicopathologic outcomes in an ethnicity-dependent man

210 ty of PDAC and to determine the surgical and clinicopathologic outcomes of pancreatic resections afte

211 n in preoperative FNAB specimens with poorer clinicopathologic outcomes of PTC.

212 c background that defines PTC with the worst clinicopathologic outcomes, providing unique prognostic

213 ween ethnicity and biomarkers for predicting clinicopathologic outcomes.

214 evels significantly correlated with advanced clinicopathologic parameters and poor OS, with optimal c

215 Clinicopathologic parameters and TRG were correlated to

216 ed between 2000 to March 2014 to investigate clinicopathologic parameters associated with (18)F-FDG a

217 tly managed by observation because available clinicopathologic parameters cannot identify the 20% to

218 output and evaluated their association with clinicopathologic parameters in common human tumor types

219 between the protein expression patterns and clinicopathologic parameters including oral cancer devel

220 proportional hazards analysis adjusting for clinicopathologic parameters shows that the high-risk gr

221 PET scoring system was developed from these clinicopathologic parameters that allowed (18)F-FDG-avid

222 By using models incorporating clinicopathologic parameters to predict prostate cancer

223 ation between the target gene expression and clinicopathologic parameters was further analyzed.

224 of MT1-MMP and EMT-associated proteins with clinicopathologic parameters were analyzed.

225 cinoma after preoperative CRT independent of clinicopathologic parameters.

226 Results were correlated with clinicopathologic parameters.

227 Clinicopathologic predictors and melanoma-specific survi

228 Clinicopathologic predictors of EBL were identified usin

229 Clinicopathologic predictors of local and locoregional d

230 Y OF BACKGROUND DATA: Despite well-described clinicopathologic predictors of posttransplant HCC recur

231 This report increases the range of clinicopathologic presentations of C9ORF72 expanded hexa

232 Clinicopathologic profiles between resection and transpl

233 ltivariable analyses accounting for standard clinicopathologic prognostic factors (10-year biochemica

234 ell-validated genomic assays such as RS with clinicopathologic prognostic factors for chemotherapy in

235 in BLBC (P = 0.0001), independently of other clinicopathologic prognostic factors including lymph nod

236 factor used in the stratified randomization, clinicopathologic prognostic factors, and other factors

237 ined significant when adjusted for all other clinicopathologic prognostic factors.

238 efine a distinct genetic subtype that shares clinicopathologic properties with clinically confirmed s

239 ignaling components in primary HCC and their clinicopathologic relevance and significance was evaluat

240 An FFGED achieved clinicopathologic remission in 54% of adult patients wit

241 enty-eight of the 52 patients (54%) achieved clinicopathologic remission on the FFGED and 6 of the 19

242 MT resolved with EoE treatments that induced clinicopathologic remission with reduced eosinophil coun

243 mined size of the primary tumor best predict clinicopathologic response of breast cancer after one cy

244 c factor for overall survival independent of clinicopathologic risk factors and a trained profile.

245 azard ratios (HRs), adjusted for significant clinicopathologic risk factors, were used to determine t

246 patients with BRAF V600E was independent of clinicopathologic risk factors.

247 endent c-indices were constructed to compare clinicopathologic risk models with the clinical-genomic

248 es useful additional information to existing clinicopathologic scoring systems of prostate cancer and

249 It will be important to perform a larger clinicopathologic series to aid our anatomic interpretat

250 were developed to assess the association of clinicopathologic (sex, age, race/ethnicity, comorbiditi

251 However, aberrant miRNA expression and its clinicopathologic significance in human ovarian cancer h

252 are emerging targets in oncology, but their clinicopathologic significance in thyroid cancer is uncl

253 We sought to determine the frequency and clinicopathologic significance of ATR mutations in patie

254 The clinicopathologic significance of mismatch repair (MMR)

255 The aim of this study was to investigate the clinicopathologic significance of Sam68 expression and i

256 peats (EMAST), but little is known about the clinicopathologic significance of these features.

257 e reverse transcriptase PCR to determine its clinicopathologic significance.

258 stical analyses were applied to evaluate the clinicopathologic significance.

259 e, for which prognosis has been relegated to clinicopathologic staging for decades.

260 This large, prospective, clinicopathologic study enrolled patients who filled out

261 Two different clinicopathologic subtypes are recognized: the estrogen-

262 HIT is a clinicopathologic syndrome characterized by thrombocytop

263 Associations with clinicopathologic traits and patient outcomes were exami

264 cohorts (n = 315) matching patients based on clinicopathologic variables (luminal B 10-year metastasi

265 hese molecular variables in combination with clinicopathologic variables (patient age, Breslow depth,

266 ly greater than a model that only considered clinicopathologic variables and also performed well in t

267 r to prognostic prediction based on standard clinicopathologic variables and P16/CDNK2A status (accur

268 Clinicopathologic variables and prognostic biomarkers SM

269 MSI and MLH1 methylation are associated with clinicopathologic variables and survival outcomes in a l

270 Associations with clinicopathologic variables and survival outcomes were e

271 ge-cell/anaplastic (LC/A) phenotype were the clinicopathologic variables associated with poor progres

272 omic classifier in combination with standard clinicopathologic variables can generate a simple-to-use

273 adhesion-linked gene expression variables to clinicopathologic variables improves the identification

274 Clinicopathologic variables included patient age and sex

275 Comparison of microRNA microarray data with clinicopathologic variables revealed a negative correlat

276 ature-derived relative risk ratios for seven clinicopathologic variables to predict ipsilateral breas

277 The DCIS nomogram integrates 10 clinicopathologic variables to provide an individualized

278 Clinicopathologic variables were analyzed for associatio

279 The relationships between MMR classes and clinicopathologic variables were assessed using continge

280 Clinicopathologic variables were compared between tumors

281 mount pathologic analysis was performed, and clinicopathologic variables were correlated with disease

282 Clinicopathologic variables were tested using univariate

283 , associations with biological pathways, and clinicopathologic variables were the main outcomes.

284 The integration of clinicopathologic variables with imaging and biomarker d

285 The relation between the LMR, clinicopathologic variables, and other biomarkers were a

286 luated the association of sociodemographics, clinicopathologic variables, and SHS with either smoking

287 tions between genotypes, protein expression, clinicopathologic variables, and survival was assessed.

288 is of individual patient data, adjusting for clinicopathologic variables, Decipher remained a statist

289 After adjusting for clinicopathologic variables, detectable adducts were not

290 machine learning to develop a model based on clinicopathologic variables, histologic tumor characteri

291 The relationships between mutations and clinicopathologic variables, including overall and disea

292 ociations between final staging outcomes and clinicopathologic variables, including SLN tumor burden,

293 years, n = 211) were compared by prognosis, clinicopathologic variables, mRNA expression values, sin

294 rial cancers to assess the relationship with clinicopathologic variables, patient survival and associ

295 Using clinicopathologic variables, young women illustrated low

296 oor clinical outcome is independent of these clinicopathologic variables.

297 dditional prognostic information to standard clinicopathologic variables.

298 ent of breast cancer is based on traditional clinicopathologic variables.

299 nd lymph node metastasis, but not with other clinicopathologic variables.

300 ures of PSP indicate that there are distinct clinicopathologic variants of PSP.